VIA
BLTE

Virtus Investment Advisers’s Belite Bio BLTE Stock Holding History

Virtus Investment Advisers’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$308K Buy
1,929
+47
+2% +$7.9K 0.08% 273
2025
Q4 		$301K Buy
1,882
+51
+3% +$6.04K 0.08% 255
2025
Q3 		$135K Buy
1,831
+318
+21% +$20.9K 0.04% 393
2025
Q2 		$87.3K Sell
1,513
-1,076
-42% -$65.6K 0.03% 394
2025
Q1 		$171K Buy
+2,589
New +$156K 0.05% 283

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtus Investment Advisers's BLTE Position: Q1 2026 in Review

Virtus Investment Advisers increased its Belite Bio (BLTE) stake by 2.5% in Q1 2026, buying an estimated $7.9K and bringing the position to 1,929 shares worth $308K. The position accounts for 0.08% of the portfolio, ranked #273.

Virtus Investment Advisers first reported a position in BLTE in Q1 2025 and has held it in 5 quarters since. 75 funds tracked by Wall St. Rank hold BLTE as of Q1 2026.

  • Virtus Investment Advisers held 1,929 shares of Belite Bio worth $308K as of Q1 2026.
  • Virtus Investment Advisers bought 47 Belite Bio shares in Q1 2026, an estimated $7.9K.
  • Belite Bio made up 0.08% of Virtus Investment Advisers's portfolio in Q1 2026, its #273 holding.
  • Virtus Investment Advisers first reported a position in Belite Bio in Q1 2025 and has held it in 5 quarters since.
  • 75 funds tracked by Wall St. Rank held Belite Bio as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.